A Grand Solution by

Our project partners:

dtu
DTU’s objective is to be a national centre for technological development through education, research, innovation, and scientific consultancy.
Our focus is technical-scientific research which contributes to the development of society. 
steno
SDCN is a part of Aalborg University Hospital and The North Denmark Region. The mission of Steno Diabetes Center North Denmark is to strengthen the diabetes efforts in Denmark by creating an internationally leading treatment and research environment to benefit patients and citizens with diabetes
aau
Aalborg University provides high-quality research within natural sciences, social sciences, humanities and engineering and health sciences and focuses on strong national and international world class research groups representing the academic areas of the University.
novo_nordisk
Novo Nordisk is a global healthcare company with more than 95 years of innovation and leadership in diabetes care. This heritage has given us experience and capabilities that also enable us to help people defeat obesity, haemophilia, growth disorders and other serious chronic diseases.

Line Systems provides a platform for aggregation and visualisation of diabetes related data. This means healthcare providers can spend more focused time on engaging with the person living with diabetes. The clinics are data controllers meaning that data researchers are able to analyse on a population level for research and clinic quality control
steno-zealand
SDCZ was established in 2019 by a donation by the Novo Nordisk Foundation. The aim of Steno Diabetes Center Zealand is that every person with diabetes in the Region can live longer with a higher quality of life. In addition, the centre will especially focus on minimizing the risk of socially disadvantaged people developing diabetes.

Previous
Next